Article
The cytotoxicity of chemotherapy drugs varies in cervical cancer cells depending on the p53 status.
Cancer biology & therapy - 1 Nov 2004
Koivusalo Riku, Hietanen Sakari
Abstract excerpt
Metastatic cervical cancer remains a clinical problem. The development of more efficient treatment modalities and the optimal use of chemo- and radiotherapy require better understanding of their impact on regulation of cell survival and apoptosis, but the issue is insufficiently explored. Human papillomavirus (HPV) E6 protein is present in nearly all cervical cancers, targeting the p53 tumor suppressor protein...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
